Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 111-120 of 144 for kidney and hypertension

Edit search filters
  1. A Study to Learn More About Improving Mesenchymal Stem Cells and Its Application in Chronic Kidney Disease Due to Hypertensive Nephropathy

    Rochester, MN

  2. Descriptive Analysis of Gut Microbiome Alterations in Hyperoxaluric Patients

    Rochester, MN

  3. Rapid Detection of Acute Kidney Injury (AKI) in Hospitalized Patients

    Scottsdale/Phoenix, AZ

  4. Predicting Stone Recurrence on CT Scan

    Jacksonville, FL, Rochester, MN

  5. Systolic Pressure Intervention Trial Factors Affecting Atherosclerosis Study

    Jacksonville, FL

  6. A Study of Patients with Primary Hyperoxaluria Type 3 with a History of Stone Events

    Rochester, MN

  7. New Quantitive MRI Parameters in Assessing Kidneys of Autosomal Dominant Polycystic Kidney Disease

    Rochester, MN

  8. Prospective, Multi-center, Single-arm, Observational Study. US FDA 522 Pediatric Post Market Surveillance Study.

    Rochester, MN

  9. TruGraf® Long-term Clinical Outcomes Study

    Scottsdale/Phoenix, AZ

  10. Assessment of ProEnkephalin to Detect Acute Kidney Injury (AKI) in Patients Hospitalized for Volume Overload Decompensated Chronic Heart Failure

    Rochester, MN

.

Mayo Clinic Footer